|
000
| 01650nam##2200289za#4500 |
|---|
| 001 | 9.650294 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20220107103649 |
|---|
| 007 | ta |
|---|
| 008 | 150407|2006||||xxc||||| f|0| 0 eng|d |
|---|
| 020 | |a0-662-43990-2 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-4/1-2006E |
|---|
| 110 | 2 |aCentre for Infectious Disease Prevention and Control (Canada) |
|---|
| 245 | 10|aI Track - enhanced surveillance of risk behaviours among injecting drug users in Canada : |bPhase I report / |cpresented by the Surveillance and Risk Assessment Division. |
|---|
| 260 | |aOttawa - Ontario : |bPublic Health Agency of Canada. |c©2006. |
|---|
| 300 | |axi, 78, ii, 15p. : |breferences, tables ; |c28 cm. |
|---|
| 520 | 3 |aThis report presents statistics from Phase I of I-Track, an enhanced surveillance system to track risk behaviours associated with HIV and hepatitis C virus (HCV) among injecting drug users (IDUs). It aims to describe changing patterns in drug injecting practices, HIV- and HCV-testing behaviours, and sexual behaviours among IDUs. Tables present data on recruitment, prevalence of HIV and HCV, drug use and other behaviours, and demographics of the study population. |
|---|
| 563 | |aSoftcover |
|---|
| 590 | |a08-04|b2008-01-25 |
|---|
| 690 | 07|aDrug use|2gcpds |
|---|
| 690 | 07|aBehaviour|2gcpds |
|---|
| 690 | 07|aControl|2gcpds |
|---|
| 775 | 08|tI Track - Surveillance améliorée des comportements à risque chez les utilisateurs de drogues injectables au Canada : |w(CaOODSP)9.683411 |
|---|
| 776 | 0#|tI Track - enhanced surveillance of risk behaviours among injecting drug users in Canada : |w(CaOODSP)9.688789 |
|---|